ゼリア新薬工業の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2024/09/09 | 2,234 | 2,270 | 2,225 | 2,265 | +13 | +0.6% | 61,400 |
| 2024/09/06 | 2,263 | 2,278 | 2,246 | 2,252 | +1 | ±0% | 44,700 |
| 2024/09/05 | 2,226 | 2,265 | 2,224 | 2,251 | +7 | +0.3% | 59,700 |
| 2024/09/04 | 2,229 | 2,269 | 2,224 | 2,244 | -15 | -0.7% | 76,000 |
| 2024/09/03 | 2,263 | 2,273 | 2,242 | 2,259 | +16 | +0.7% | 48,800 |
| 2024/09/02 | 2,301 | 2,301 | 2,230 | 2,243 | -68 | -2.9% | 79,000 |
| 2024/08/30 | 2,285 | 2,324 | 2,280 | 2,311 | +41 | +1.8% | 109,900 |
| 2024/08/29 | 2,275 | 2,284 | 2,262 | 2,270 | -8 | -0.4% | 36,100 |
| 2024/08/28 | 2,292 | 2,296 | 2,263 | 2,278 | -5 | -0.2% | 29,700 |
| 2024/08/27 | 2,289 | 2,299 | 2,281 | 2,283 | +1 | ±0% | 29,800 |
| 2024/08/26 | 2,272 | 2,283 | 2,257 | 2,282 | +8 | +0.4% | 37,100 |
| 2024/08/23 | 2,269 | 2,285 | 2,255 | 2,274 | +27 | +1.2% | 69,100 |
| 2024/08/22 | 2,224 | 2,256 | 2,224 | 2,247 | +39 | +1.8% | 50,900 |
| 2024/08/21 | 2,200 | 2,223 | 2,200 | 2,208 | -9 | -0.4% | 25,400 |
| 2024/08/20 | 2,200 | 2,225 | 2,194 | 2,217 | +28 | +1.3% | 40,600 |
| 2024/08/19 | 2,184 | 2,203 | 2,181 | 2,189 | -11 | -0.5% | 28,400 |
| 2024/08/16 | 2,196 | 2,200 | 2,174 | 2,200 | +31 | +1.4% | 47,700 |
| 2024/08/15 | 2,170 | 2,170 | 2,136 | 2,169 | +11 | +0.5% | 29,700 |
| 2024/08/14 | 2,130 | 2,165 | 2,130 | 2,158 | +28 | +1.3% | 33,000 |
| 2024/08/13 | 2,095 | 2,130 | 2,076 | 2,130 | +38 | +1.8% | 38,600 |
| 2024/08/09 | 2,128 | 2,128 | 2,061 | 2,092 | +8 | +0.4% | 76,400 |
| 2024/08/08 | 2,050 | 2,127 | 2,020 | 2,084 | -11 | -0.5% | 54,000 |
| 2024/08/07 | 2,090 | 2,166 | 2,067 | 2,095 | +12 | +0.6% | 73,800 |
| 2024/08/06 | 2,059 | 2,115 | 2,042 | 2,083 | +74 | +3.7% | 100,200 |
| 2024/08/05 | 1,989 | 2,108 | 1,970 | 2,009 | -106 | -5% | 118,300 |
| 2024/08/02 | 2,234 | 2,240 | 2,102 | 2,115 | -69 | -3.2% | 164,400 |
| 2024/08/01 | 2,180 | 2,220 | 2,166 | 2,184 | -9 | -0.4% | 98,300 |
| 2024/07/31 | 2,165 | 2,193 | 2,152 | 2,193 | +30 | +1.4% | 44,500 |
| 2024/07/30 | 2,157 | 2,170 | 2,154 | 2,163 | -8 | -0.4% | 41,000 |
| 2024/07/29 | 2,160 | 2,177 | 2,160 | 2,171 | +16 | +0.7% | 33,300 |
| 2024/07/26 | 2,160 | 2,171 | 2,147 | 2,155 | +5 | +0.2% | 55,100 |
| 2024/07/25 | 2,158 | 2,167 | 2,135 | 2,150 | +9 | +0.4% | 67,100 |
| 2024/07/24 | 2,152 | 2,164 | 2,135 | 2,141 | -20 | -0.9% | 24,300 |
| 2024/07/23 | 2,143 | 2,164 | 2,143 | 2,161 | +18 | +0.8% | 29,400 |
| 2024/07/22 | 2,160 | 2,160 | 2,130 | 2,143 | -9 | -0.4% | 29,600 |
| 2024/07/19 | 2,139 | 2,156 | 2,128 | 2,152 | +13 | +0.6% | 42,300 |
| 2024/07/18 | 2,120 | 2,161 | 2,115 | 2,139 | +16 | +0.8% | 51,100 |
| 2024/07/17 | 2,140 | 2,147 | 2,114 | 2,123 | -7 | -0.3% | 32,500 |
| 2024/07/16 | 2,152 | 2,160 | 2,126 | 2,130 | -20 | -0.9% | 32,000 |
| 2024/07/12 | 2,143 | 2,160 | 2,140 | 2,150 | +5 | +0.2% | 57,100 |
| 2024/07/11 | 2,146 | 2,156 | 2,121 | 2,145 | +56 | +2.7% | 72,200 |
| 2024/07/10 | 2,100 | 2,100 | 2,069 | 2,089 | +7 | +0.3% | 45,400 |
| 2024/07/09 | 2,051 | 2,091 | 2,051 | 2,082 | +16 | +0.8% | 37,800 |
| 2024/07/08 | 2,076 | 2,093 | 2,065 | 2,066 | -9 | -0.4% | 37,600 |
| 2024/07/05 | 2,118 | 2,125 | 2,074 | 2,075 | -43 | -2% | 33,700 |
| 2024/07/04 | 2,115 | 2,120 | 2,111 | 2,118 | -1 | ±0% | 17,700 |
| 2024/07/03 | 2,117 | 2,125 | 2,112 | 2,119 | +2 | +0.1% | 22,500 |
| 2024/07/02 | 2,096 | 2,143 | 2,092 | 2,117 | +25 | +1.2% | 75,300 |
| 2024/07/01 | 2,113 | 2,118 | 2,082 | 2,092 | -21 | -1% | 43,400 |
| 2024/06/28 | 2,117 | 2,117 | 2,100 | 2,113 | +3 | +0.1% | 43,500 |
51～
100
件表示中 / 3586件
類似銘柄と比較する
現在ご覧いただいている「ゼリア新薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| ゼリア新薬 | 224,400円 | +13.6% | +29.2% | 2.05% | 11.64倍 | 1.12倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
| 鳥居薬 | 476,000円 | +12.0% | +28.1% | 2.52% | 26.24倍 | 1.11倍 |
|
ＪＴ傘下。柱の抗ＨＩＶ薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
| 持田薬 | 331,500円 | +3.0% | +27.5% | 2.41% | 20.99倍 | 0.91倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
| ネクセラファーマ | 113,200円 | +197.7% | - | 0.00% | 46.26倍 | 1.48倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
| 杏林製薬 | 149,900円 | +3.2% | +4.5% | 3.47% | 17.22倍 | 0.66倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
市場注目の銘柄
チャート関連のコラム
